Asahi Kasei Life Science, a division of Asahi Kasei Corp., is set to enhance its production capabilities by constructing a new spinning plant for Planova virus-removal filters in Nobeoka City, Japan. This strategic move aligns with the company’s growth plans outlined in the ‘Trailblaze Together’ management plan and is supported by a grant from Japan’s Ministry of Economy, Trade, and Industry.
With the global biopharmaceutical market projected to exceed US$500 billion by 2032, the demand for virus removal filters is expected to surge, making this expansion timely and crucial. The new facility will focus on producing various Planova filters to meet the escalating global demand, solidifying the company’s position as a key player in virus filtration for biologics and plasma-derived therapeutics. This investment not only enhances supply chain resilience but also strengthens Asahi Kasei’s competitiveness in the high-value bioprocessing market.
Read more on chemengonline.com